Koji Matsuo



  1. Matsuo K, Mabuchi S, Okazawa M, Matsumoto Y, Tsutsui T, Fujita M, et al. Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer. Br J Cancer. 2013;108:1348-57 pubmed publisher
    ..001). Surgical-pathological risk factors provide valuable information for survival and management of early-stage cervical cancer when number and significance of risks are weighted. ..
  2. Matsuo K, Shiki Y, Yamasaki M, Shimoya K. Use of uterine fundal pressure maneuver at vaginal delivery and risk of severe perineal laceration. Arch Gynecol Obstet. 2009;280:781-6 pubmed publisher
    ..Uterine fundal pressure maneuver during the second stage of labor increased the risk of severe perineal laceration. The use of the maneuver must be cautioned and careful attention must be paid to its application. ..
  3. Matsuo K, Bond V, Eno M, Im D, Rosenshein N. Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer. Int J Cancer. 2009;125:2721-7 pubmed publisher
  4. Matsuo K, Ahn E, Prather C, Eno M, Im D, Rosenshein N. Patient-reported symptoms and survival in ovarian cancer. Int J Gynecol Cancer. 2011;21:1555-65 pubmed publisher
    ..8 vs 17.4 vs 11.7 months [P < 0.001]; and median OS, 70 vs 41.6 vs 37.2 months [P < 0.001]). Lower extremity edema at initial diagnosis is a strong prognostic indicator of ovarian cancer patient. ..
  5. Matsuo K, Eno M, Im D, Rosenshein N. Pregnancy and genital sarcoma: a systematic review of the literature. Am J Perinatol. 2009;26:507-18 pubmed publisher
    ..Genital sarcomas in pregnancy are rare. There is a delay in diagnosis due to low index of suspicion. A majority had live births, and the 5-year survival is similar to that of advanced-stage sarcoma in nonpregnant women. ..
  6. Matsuo K, Chi D, Eno M, Im D, Rosenshein N. Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases. Gynecol Obstet Invest. 2009;68:276-8 pubmed publisher
    ..Biopsy showed mucinous adenocarcinoma. Vulvar lesions or symptoms in the setting of rectovaginal fistula in Crohn's disease are an important clinical feature and the possible development of vulvar cancer should be considered. ..
  7. Matsuo K, Sheridan T, Yoshino K, Miyake T, Hew K, Im D, et al. Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med. 2012;1:156-64 pubmed publisher
    ..16, 95% CI: 1.00-26.6, P = 0.028). The presence of LVSI is an independent predictive indicator of nodal metastasis and is associated with worse clinical outcome of patients with epithelial ovarian cancer. ..
  8. Kodama M, Grubbs B, Blake E, Cahoon S, Murakami R, Kimura T, et al. Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014;181:145-56 pubmed publisher
    ..It is suggested that early detection and tumor intervention with expectant management of pregnancy is an acceptable option in early-stage ovarian MGCT-complicated pregnancies. ..
  9. Blake E, Sheridan T, Wang K, Takiuchi T, Kodama M, Sawada K, et al. Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014;181:163-70 pubmed publisher
    ..While classic UTROSCT typically has a favorable prognosis, it has been known to develop a late recurrence. If risk factors for recurrence are absent, both hysterectomy and mass resection alone are possible options for management. ..

More Information


  1. Matsuo K, Mabuchi S, Okazawa M, Kawano M, Kuroda H, Kamiura S, et al. Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors. J Gynecol Oncol. 2015;26:3-11 pubmed publisher
    ..31 (p=0.071) and 0.99 (p=0.980), respectively. Special consideration for the significance of multiple high-risk factors merits further investigation in the management of surgically treated early-stage cervical cancer. ..
  2. Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, et al. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion. Gynecol Oncol. 2015;136:198-204 pubmed publisher
    ..009; and OS, p=0.016). LVSI is an important marker to predict survival outcome of stage I OCCC. Regardless of chemotherapy type, patients with stage I OCCC showing LVSI may benefit from receiving postoperative chemotherapy. ..
  3. Blake E, Kodama M, Yunokawa M, Ross M, Ueda Y, Grubbs B, et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2015;186:97-105 pubmed publisher
    ..01). In conclusion, although the majority of EOC cases during pregnancy resulted in live birth, maternal and neonatal mortality needs to be considered in the counseling and management of these pregnancies. ..
  4. Kodama M, Moeini A, Machida H, Blake E, Grubbs B, Matsuo K. Feto-maternal outcomes of pregnancy complicated by Krukenberg tumor: a systematic review of literature. Arch Gynecol Obstet. 2016;294:589-98 pubmed publisher
    ..58.1 %, adjusted-HR 7.95, 95 % CI 1.76-36.0, p < 0.01). Our results showed that prognosis of Krukenberg tumor complicated pregnancies is extremely poor, however it may be improved if radical surgery is achievable. ..
  5. Matsuo K, Alonsozana E, Eno M, Rosenshein N, Im D. Primary peritoneal clear cell adenocarcinoma arising in previous abdominal scar for endometriosis surgery. Arch Gynecol Obstet. 2009;280:637-41 pubmed publisher
    ..Endometriosis-associated ovarian cancer arising from the surgical incision site is an unusual clinical entity...
  6. Matsuo K, Bond V, Im D, Rosenshein N. Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay. Am J Clin Oncol. 2010;33:358-63 pubmed publisher
    ..To evaluate the role of an in vitro drug resistance assay to predict the response to platinum and taxane combination chemotherapy in advanced ovarian and uterine carcinosarcoma...
  7. Matsuo K, Eno M, Ahn E, Shahzad M, Im D, Rosenshein N, et al. Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer. Am J Clin Oncol. 2011;34:488-93 pubmed publisher
    ..002). Increased expression of MDR-1 in the tumor tissue obtained at initial cytoreduction is associated with increased risk of developing brain metastases in women with epithelial ovarian, fallopian tube, or peritoneal cancer. ..